Pharmaceutical News and Articles

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

Apple Will Sell Air Pods With Hearing Aids Built In

The latest AirPods from Apple will come with built-in hearing aids, the company announced Monday. Designed as an over-the-counter hearing aid feature for those

Could Sulthiame, a Pill Approved in Europe for Epilepsy, Help Ease Sleep Apnea?

A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame had few pauses in their breathing wh

Pandemic Isolation May Have Caused Rapid Brain Aging in Teen Girls

New research uncovers a possible reason why teenaged girls struggled so mightily with their mental health during the pandemic Scans showed their brains aged far

Asthma Could Raise Miscarriage, Infertility Risks for Women: Study

Having asthma appears linked to raised odds for miscarriage and troubles with fertility among women, new Danish research shows. We found that women fulfilling t

No Advantage Seen With Long-Term Oxygen Therapy for 24 Versus 15 Hours/Day

For patients starting long-term oxygen therapy for chronic, severe hypoxemia at rest, the risk for hospitalization or death within one year is comparable with l

U.S. Suicide Rates Rise in Less Affluent Areas

An analysis of where suicides are occurring in the United States shows that, tragically, location matters. People living in poorer areas with fewer resources ar

Depemokimab Cuts Exacerbation Rate in Eosinophilic Asthma

For patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, according to a study published online

Weight-Loss Surgery Benefits Blood Pressure Management

Bariatric surgery emerges as a durable solution for obesity-related hypertension, according to a study presented at the American Heart Association Hypertension

Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer

Omission of 5-fluorouracil (5-FU) from the first-line FOLFOX, FOLFIRI, and FOLFIRINOX regimens is not associated with reduced survival among patients with advan